Company: NCEL
Filing Date: 2025-03-31
Form Type: F-4/A
Source: 0001213900-25-026428
Chunk: 878

Company: NewcelX Ltd.
Filing Date: 2025-03-31
Form: F-4/A
Chunk 878
---
 Prof. Michel Revel as member of the Board of Directors: [citizen of], [residing in] FOR AGAINST ABSTAIN Mr. Eran Iohan as member of the Board of Directors: [citizen of], [residing in] FOR AGAINST ABSTAIN Ms. Liora Oren as member of the Board of Directors: [citizen of], [residing in] FOR AGAINST ABSTAIN Ms. Tammy Galili as member of the Board of Directors: [citizen of], [residing in] FOR AGAINST ABSTAIN 3. Election of the members of the Compensation, Nomination and Governance Committee Due to the transactions contemplated by the Merger and the renewal of the Board of Directors, the board proposes to elect the following persons individually as members of the Compensation, Nomination and Governance Committee for a term of office until the conclusion of the next ordinary Annual Shareholders Meeting. Mr. Olivier Samuel FOR AGAINST ABSTAIN Mr. Eran Lohan FOR AGAINST ABSTAIN Ms. Liora Oren FOR AGAINST ABSTAIN 4. Advisory vote: Composition of the new Senior Management following the Merger Due to the transactions contemplated by the Merger, the Company’s senior management is intended to be newly constituted. The board proposes that the Extraordinary Shareholders Meeting approves the election of the following persons to the senior management in the sense of an advisory vote: Mr. Ronen Twito Prof. Michel Revel Mr. Kfir Malkandov Mr. Ariel Revel FOR AGAINST ABSTAIN 5. Compensation for the Members of the Board of Directors and Executive Management 5.1. Approval of the compensation for the Board of Directors The board proposes to adjust the compensation for the Board of Directors, due to the transactions contemplated by the Merger, to a new maximum aggregate amount of CHF [●] for the fixed compensation of the Board of Directors. Furthermore the board proposes to set the grant of equity or equity linked instruments at a maximum aggregate amount of CHF [●] for the compensation of Board of Directors and the board proposes the participation in the purchase of a run-off insurance policy for the members of the Board of Directors, to be effective at the time of the merger’s completion, with coverage amounts and terms to be approved by the Board of Directors, in each case for the current term of office until the next Ordinary Shareholders Meeting. FOR AGAINST ABSTAIN 5.2. Approval of the compensation for the executive officers The